TEC Finds iFOBT Test Evidence Lacking In Contrast To Medicare Decision
This article was originally published in The Gray Sheet
Executive Summary
A 1BlueCross BlueShield Association TEC assessment finding insufficient evidence on the use of immunochemical fecal occult blood tests contradicts a recent positive Medicare national coverage decision